Amylyx Pharmaceuticals, Inc. - Common Stock — Cash Flow (NASDAQ:AMLX) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities -179.87 M11.92 M-167.65 M-123.34 M -120.4 M Cash from investing activities -238.99 M92.05 M75.65 M14.04 M 93.96 M Cash from financing activities 431.79 M3.54 M348 K257.03 M 194.58 M Free cash flow -179.87 M11.92 M-167.65 M-123.34 M -120.4 M

News

H.C. Wainwright raises Amylyx stock price target to $34 on trial confidence

Amylyx shares fall over 3% on trial uncertainty despite earnings beat

Stifel initiates Amylyx stock with buy rating on drug potential

Amylyx set to report earnings as avexitide trial nears finish

Amylyx stock price target raised to $28 from $20 at H.C. Wainwright

Amylyx Pharmaceuticals: Back From The Dead (NASDAQ:AMLX)

Amylyx Pharmaceuticals stock hits 52-week high at $16.96

Amylyx pharma co-CEO Cohen sells $1.87m in shares

Amylyx pharma co-CEO Klee sells $1.88 million in AMLX stock

Mizuho reiterates Outperform rating on Amylyx stock, cites GLP-1 program

Amylyx Pharma director Firestone buys $100k in AMLX stock

TD Cowen analyst highlights 10+ potential biotech catalysts for 2026